General Information of Drug (ID: DMY57L0)

Drug Name
melanin-concentrating hormone Drug Info
Synonyms Melanin-concentrating hormone; Melanin concentrating hormone; GTPL1298
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
16167454
TTD Drug ID
DMY57L0

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
BMS-830216 DMCW71N Obesity 5B81 Phase 1 [4]
AZD1979 DMQ1OX4 Obesity 5B81 Phase 1 [5]
PMID25522065-Compound-27 DMXN4KB N. A. N. A. Patented [6]
PMID25522065-Compound-29 DMBNAK9 N. A. N. A. Patented [6]
PMID25522065-Compound-34 DMZDIRQ N. A. N. A. Patented [6]
PMID25522065-Compound-39 DM5YMQH N. A. N. A. Patented [6]
PMID25522065-Compound-40 DMCIQ01 N. A. N. A. Patented [6]
PMID25522065-Compound-11 DM410Z6 N. A. N. A. Patented [6]
PMID25522065-Compound-50 DMBWA0V N. A. N. A. Patented [6]
PMID25522065-Compound-12 DMVKO9C N. A. N. A. Patented [6]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ATC0065 DMJNQ5G Discovery agent N.A. Investigative [7]
PMID22123324C38 DMZ5BHX Discovery agent N.A. Investigative [8]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Melanin-concentrating hormone receptor 1 (MCHR1) TTX4RTB MCHR1_HUMAN Agonist [2]
Melanin-concentrating hormone receptor 2 (MCHR2) TTS17MG MCHR2_HUMAN Agonist [3]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1298).
2 [125I]-S36057: a new and highly potent radioligand for the melanin-concentrating hormone receptor. Br J Pharmacol. 2001 Jun;133(3):371-8.
3 Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R. Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7564-9.
4 2011 Pipeline of Bristol-Myers Squibb.
5 Phase I clinical trial of AZD1979 for treating obesity. AstraZeneca plc
6 Novel MCH1 receptor antagonists: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):193-207.
7 Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagoni... J Pharmacol Exp Ther. 2005 May;313(2):831-9.
8 Discovery and characterization of a potent and selective antagonist of melanin-concentrating hormone receptor 2. Bioorg Med Chem Lett. 2012 Jan 1;22(1):363-6.